Thomas R - Search Results

1

Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis.

Scally SW, Law SC, Ting YT, Heemst JV, Sokolove J, Deutsch AJ, Bridie Clemens E, Moustakas AK, Papadopoulos GK, van der Woude D, Smolik I, Hitchon CA, Robinson DB, Ferucci ED, Bernstein CN, Meng X, Anaparti V, Huizinga T, Kedzierska K, Reid HH, Raychaudhuri S, Toes RE, Rossjohn J, El-Gabalawy H, Thomas R. Scally SW, et al. Among authors: thomas r. Ann Rheum Dis. 2017 Nov;76(11):1915-1923. doi: 10.1136/annrheumdis-2017-211300. Epub 2017 Aug 11. Ann Rheum Dis. 2017. PMID: 28801345 Free PMC article.

2

T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles.

Law SC, Street S, Yu CH, Capini C, Ramnoruth S, Nel HJ, van Gorp E, Hyde C, Lau K, Pahau H, Purcell AW, Thomas R. Law SC, et al. Among authors: thomas r. Arthritis Res Ther. 2012 May 17;14(3):R118. doi: 10.1186/ar3848. Arthritis Res Ther. 2012. PMID: 22594821 Free PMC article.

3

A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis.

Scally SW, Petersen J, Law SC, Dudek NL, Nel HJ, Loh KL, Wijeyewickrema LC, Eckle SB, van Heemst J, Pike RN, McCluskey J, Toes RE, La Gruta NL, Purcell AW, Reid HH, Thomas R, Rossjohn J. Scally SW, et al. Among authors: thomas r. J Exp Med. 2013 Nov 18;210(12):2569-82. doi: 10.1084/jem.20131241. Epub 2013 Nov 4. J Exp Med. 2013. PMID: 24190431 Free PMC article.

4

Identification of self-antigen-specific T cells reflecting loss of tolerance in autoimmune disease underpins preventative immunotherapeutic strategies in rheumatoid arthritis.

Law SC, Benham H, Reid HH, Rossjohn J, Thomas R. Law SC, et al. Among authors: thomas r. Rheum Dis Clin North Am. 2014 Nov;40(4):735-52. doi: 10.1016/j.rdc.2014.07.015. Epub 2014 Sep 2. Rheum Dis Clin North Am. 2014. PMID: 25437289 Review.

5

IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis.

Anderson AE, Pratt AG, Sedhom MA, Doran JP, Routledge C, Hargreaves B, Brown PM, Lê Cao KA, Isaacs JD, Thomas R. Anderson AE, et al. Among authors: thomas r. Ann Rheum Dis. 2016 Feb;75(2):466-73. doi: 10.1136/annrheumdis-2014-205850. Epub 2015 Feb 3. Ann Rheum Dis. 2016. PMID: 25649145 Free PMC article.

6

Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens.

Koning F, Thomas R, Rossjohn J, Toes RE. Koning F, et al. Among authors: thomas r. Nat Rev Rheumatol. 2015 Aug;11(8):450-61. doi: 10.1038/nrrheum.2015.59. Epub 2015 May 19. Nat Rev Rheumatol. 2015. PMID: 25986717 Review.

7

Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients.

Benham H, Nel HJ, Law SC, Mehdi AM, Street S, Ramnoruth N, Pahau H, Lee BT, Ng J, Brunck ME, Hyde C, Trouw LA, Dudek NL, Purcell AW, O'Sullivan BJ, Connolly JE, Paul SK, Lê Cao KA, Thomas R. Benham H, et al. Among authors: thomas r. Sci Transl Med. 2015 Jun 3;7(290):290ra87. doi: 10.1126/scitranslmed.aaa9301. Sci Transl Med. 2015. PMID: 26041704

8

Genetic association of ankylosing spondylitis with TBX21 influences T-bet and pro-inflammatory cytokine expression in humans and SKG mice as a model of spondyloarthritis.

Lau MC, Keith P, Costello ME, Bradbury LA, Hollis KA, Thomas R, Thomas GP, Brown MA, Kenna TJ. Lau MC, et al. Among authors: thomas gp, thomas r. Ann Rheum Dis. 2017 Jan;76(1):261-269. doi: 10.1136/annrheumdis-2015-208677. Epub 2016 Apr 28. Ann Rheum Dis. 2017. PMID: 27125523

9

The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis.

Ting YT, Petersen J, Ramarathinam SH, Scally SW, Loh KL, Thomas R, Suri A, Baker DG, Purcell AW, Reid HH, Rossjohn J. Ting YT, et al. Among authors: thomas r. J Biol Chem. 2018 Mar 2;293(9):3236-3251. doi: 10.1074/jbc.RA117.001013. Epub 2018 Jan 9. J Biol Chem. 2018. PMID: 29317506 Free PMC article.

10

Flow Cytometric Clinical Immunomonitoring Using Peptide-MHC Class II Tetramers: Optimization of Methods and Protocol Development.

Jansen DTSL, Ramnoruth N, Loh KL, Rossjohn J, Reid HH, Nel HJ, Thomas R. Jansen DTSL, et al. Among authors: thomas r. Front Immunol. 2018 Jan 22;9:8. doi: 10.3389/fimmu.2018.00008. eCollection 2018. Front Immunol. 2018. PMID: 29403492 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,477 results

Search Page

Filters